Home › Funds › BlackRock Inc › STRO
BlackRock Inc position in STRO
SUTRO BIOPHARMA INC · Health Care
Latest position (Q2 2026)1.12M sh
Reported value held$37.27M
Portfolio Weight0.00%
First reportedQ3 2024
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 7.02M | $24.28M | New |
| Q4 2024 | 7.59M | $13.97M | Add |
| Q1 2025 | 6.20M | $4.04M | Reduce |
| Q2 2025 | 2.11M | $1.50M | Reduce |
| Q3 2025 | 1.69M | $1.47M | Reduce |
| Q4 2025 | 117.44K | $1.36M | Reduce |
| Q1 2026 | 232.68K | $5.80M | Add |
| Q2 2026 | 1.12M | $37.27M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding STRO
- Balyasny Asset Management 711.16K sh · $23.61M · Q2 2026
- Geode Capital Management 389.69K sh · $12.94M · Q2 2026
- Millennium Management 365.97K sh · $12.15M · Q2 2026
- Point72 Asset Management 237.83K sh · $7.90M · Q2 2026
- UBS Group AG 208.51K sh · $6.92M · Q2 2026
- Two Sigma Investments 201.69K sh · $6.70M · Q2 2026
- Marshall Wace 175.25K sh · $5.82M · Q2 2026
- JPMorgan Chase & Co 159.63K sh · $5.32M · Q2 2026
- Goldman Sachs Group 149.22K sh · $4.95M · Q2 2026
- Vanguard Group 375.79K sh · $4.35M · Q4 2025
- Northern Trust Corp 125.93K sh · $4.18M · Q2 2026